- Patent Title: HSP90 targeted conjugates and particles and formulations thereof
-
Application No.: US16079387Application Date: 2017-02-23
-
Publication No.: US10548881B2Publication Date: 2020-02-04
- Inventor: Rajesh R. Shinde , Mark T. Bilodeau , Richard Wooster , Sudhakar Kadiyala
- Applicant: TARVEDA THERAPEUTICS, INC.
- Applicant Address: US MA Watertown
- Assignee: TARVEDA THERAPEUTICS, INC.
- Current Assignee: TARVEDA THERAPEUTICS, INC.
- Current Assignee Address: US MA Watertown
- Agency: DT Ward, PC
- Agent Donna T. Ward; Heng Zhu
- International Application: PCT/US2017/019040 WO 20170223
- International Announcement: WO2017/147240 WO 20170831
- Main IPC: A61K31/437
- IPC: A61K31/437 ; A61K47/54 ; A61K47/64 ; A61K9/51 ; A61P35/00 ; A61K9/00

Abstract:
Conjugates of an active agent such as a therapeutic, prophylactic, or diagnostic agent attached to an HSP90 targeting moiety via a linker have been designed. Nanoparticles and microparticles comprising such conjugates can provide improved temporospatial delivery of the active agent and/or improved biodistribution. Methods of making the conjugates, the particles, and the formulations thereof are provided. Methods of administering the formulations to a subject in need thereof are provided, for example, to treat or prevent cancer or other diseases.
Public/Granted literature
- US20190054072A1 HSP90 TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF Public/Granted day:2019-02-21
Information query
IPC分类: